• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4785012)   Today's Articles (2926)
For: Weng MT, Yang PJ, Liu PF, Chang CH, Lee HS, Sheu JC, Nien HC. Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Hepatol Int 2025;19:405-414. [PMID: 39625600 DOI: 10.1007/s12072-024-10758-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Accepted: 11/15/2024] [Indexed: 04/17/2025]
Number Cited by Other Article(s)
1
Dalai MK, Chandnani SJ. Response to: Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Hepatol Int 2025:10.1007/s12072-025-10803-9. [PMID: 40159418 DOI: 10.1007/s12072-025-10803-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2025] [Accepted: 02/16/2025] [Indexed: 04/02/2025]
2
Dalai MK, Chandnani SJ. Letter: Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Hepatol Int 2025:10.1007/s12072-025-10798-3. [PMID: 40009288 DOI: 10.1007/s12072-025-10798-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2025] [Accepted: 02/10/2025] [Indexed: 02/27/2025]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA